596 related articles for article (PubMed ID: 19667571)
1. Clinical implications. In vitro resistance of E coli to TMP/SMX.
Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
[No Abstract] [Full Text] [Related]
2. In vitro resistance of E coli to TMP/SMX and clinical failure.
Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
[No Abstract] [Full Text] [Related]
3. Increasing in vitro resistance of E coli to TMP/SMX.
Postgrad Med; 2001 Aug; 110(2 Suppl):5-8; discussion 26-7. PubMed ID: 19667569
[No Abstract] [Full Text] [Related]
4. The role of clinical guidelines.
Postgrad Med; 2001 Aug; 110(2 Suppl):16-20; discussion 26-7. PubMed ID: 19667572
[No Abstract] [Full Text] [Related]
5. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
Brown PD; Freeman A; Foxman B
Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
[TBL] [Abstract][Full Text] [Related]
7. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis.
Le TP; Miller LG
Clin Infect Dis; 2001 Sep; 33(5):615-21. PubMed ID: 11486284
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
Guneysel O; Onur O; Erdede M; Denizbasi A
J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
[TBL] [Abstract][Full Text] [Related]
9. Urinary tract infection.
Talan DA
N Engl J Med; 2003 Oct; 349(17):1674-6; author reply 1674-6. PubMed ID: 14573744
[No Abstract] [Full Text] [Related]
10. Escherichia coli resistance in uncomplicated urinary tract infection: a model for determining when to change first-line empirical antibiotic choice.
Perfetto EM; Gondek K
Manag Care Interface; 2002 Jun; 15(6):35-42. PubMed ID: 12087605
[TBL] [Abstract][Full Text] [Related]
11. Addressing antibiotic resistance.
Gupta K
Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
[TBL] [Abstract][Full Text] [Related]
12. Urinary infections due to multi-drug-resistant Escherichia coli among persons with HIV disease at a tertiary AIDS care centre in South India.
Vignesh R; Shankar EM; Murugavel KG; Kumarasamy N; Sekar R; Irene P; Solomon S; Balakrishnan P
Nephron Clin Pract; 2008; 110(1):c55-7. PubMed ID: 18724067
[TBL] [Abstract][Full Text] [Related]
13. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
[TBL] [Abstract][Full Text] [Related]
14. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.
Nguyen HT; Hurwitz RS; Defoor WR; Minevich E; McAdam AJ; Mortensen JE; Novak-Weekley SM; Minnillo BJ; Elder JS
J Urol; 2010 Jul; 184(1):305-10. PubMed ID: 20488468
[TBL] [Abstract][Full Text] [Related]
15. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
Rock W; Colodner R; Chazan B; Elias M; Raz R
Isr Med Assoc J; 2007 Nov; 9(11):803-5. PubMed ID: 18085038
[TBL] [Abstract][Full Text] [Related]
16. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
Can F; Azap OK; Seref C; Ispir P; Arslan H; Ergonul O
Clin Infect Dis; 2015 Feb; 60(4):523-7. PubMed ID: 25378460
[TBL] [Abstract][Full Text] [Related]
17. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
[TBL] [Abstract][Full Text] [Related]
18. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
[TBL] [Abstract][Full Text] [Related]
19. Does in vitro fluoroquinolone resistance predict clinical failure in urinary tract infections?
Miller LG; Mehrotra R; Tang AW
Int J Antimicrob Agents; 2007 May; 29(5):605-7. PubMed ID: 17293087
[No Abstract] [Full Text] [Related]
20. Urinary tract infection in women over the age of 65: is age alone a marker of complication?
Grover ML; Bracamonte JD; Kanodia AK; Edwards FD; Weaver AL
J Am Board Fam Med; 2009; 22(3):266-71. PubMed ID: 19429732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]